We are live on ! Find out more
MDCXW

Medicus Pharma Warrant

7 hedge funds and large institutions have $308K invested in Medicus Pharma Warrant in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

65% more capital invested

Capital invested by funds: $187K → $308K (+$121K)

17% more funds holding

Funds holding: 67 (+1)

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
3
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

MDCXW Hedge Fund Activity: Q1 2025 in Review

7 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Medicus Pharma Warrant (MDCXW) for Q1 2025, worth a combined $308K — up 65% from $187K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new MDCXW positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $62.8K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $26.9K sold.

  • 7 institutional investors held Medicus Pharma Warrant (MDCXW) as of Q1 2025, up from 6 in Q4 2024.
  • Funds reported $308K of Medicus Pharma Warrant stock for Q1 2025, up 65% quarter-over-quarter.
  • 2 funds opened new Medicus Pharma Warrant positions in Q1 2025 and 1 closed out, a net change of +1 holder.
  • The largest Medicus Pharma Warrant buyer in Q1 2025 was Armistice Capital, an estimated $62.8K added.
  • The largest Medicus Pharma Warrant seller in Q1 2025 was Hudson Bay Capital Management, an estimated $26.9K sold.

Based on aggregated 13F filings for Q1 2025.